Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Alethia BioTherapeutics Inc.
Description mAb against cell surface protein Siglec-15
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationBone repair
Indication DetailsTreat bone loss in hypercalcemia of malignancy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today